aluates Reports

$ 0.0

Automative

Global Therapeutic Drug Monitoring Market Research Report 2026

Published Date: 2026-03-02

Report Code: QYRE-Auto-18B12968

Global Therapeutic Drug Monitoring Market Research Report 2023

BUY CHAPTERS

Global Therapeutic Drug Monitoring Market Research Report 2026

Code: QYRE-Auto-18B12968

Report

2026-03-02

Pages:116

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Danaher

Abbott

Thermo Fisher Scientific

Siemens Healthineers

Bio Rad Laboratories

Biomerieux

Bühlmann Laboratories

Randox Laboratories

SEKISUI Medical

Chromai

DAT Diagnostic

Therapeutic Drug Monitoring Market Size

The global Therapeutic Drug Monitoring market was valued at US$ 2315 million in 2025 and is anticipated to reach US$ 4146 million by 2032, at a CAGR of 8.8% from 2026 to 2032.

Therapeutic Drug Monitoring Market

Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs. Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.

The Therapeutic Drug Monitoring (TDM) market is growing due to an increasing focus on personalized medicine, which tailors treatments to the individual characteristics of each patient. TDM enables clinicians to optimize drug dosages for better efficacy and reduced toxicity, particularly important for drugs with narrow therapeutic windows, such as immunosuppressants, anti-epileptics, and certain antibiotics. As the incidence of chronic diseases rises globally, there is greater demand for precise dosing in treatments, which supports TDM's expanding role. Additionally, technological advancements in laboratory automation and assay sensitivity are making TDM more accessible and accurate, further driving market growth.

A significant challenge in the TDM market is the high cost of testing and the need for specialized equipment and expertise, which can limit its accessibility, especially in lower-income regions. TDM requires sophisticated instruments and skilled personnel to interpret results accurately, leading to a barrier for healthcare facilities without sufficient resources. Furthermore, in some cases, there is a lack of standardized protocols for monitoring certain drugs, creating inconsistencies in practices across healthcare systems. These factors may hinder the widespread adoption of TDM, especially in resource-constrained settings.

Global therapeutic drug monitoring key players include Roche, Danaher and Abbott.The top 5 accounts for 60% of the revenue. By region, North America had the highest share of income, reaching 45%.In terms of product, blood test is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital labs, followed by independent clinical laboratories.

This report delivers a comprehensive overview of the global Therapeutic Drug Monitoring market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Therapeutic Drug Monitoring. The Therapeutic Drug Monitoring market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Therapeutic Drug Monitoring market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Therapeutic Drug Monitoring manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Therapeutic Drug Monitoring Market Report

Report Metric	Details
Report Name	Therapeutic Drug Monitoring Market
Accounted market size in 2025	US$ 2315 million
Forecasted market size in 2032	US$ 4146 million
CAGR	8.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Blood Test Urine Test Saliva Test
Segment by Application	Hospital Labs Independent Clinical Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, bioMerieux, Bühlmann Laboratories, Randox Laboratories, Sekisui Medical, DAT Diagnostic, Chromai
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Therapeutic Drug Monitoring companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Therapeutic Drug Monitoring Market growing?

Ans: The Therapeutic Drug Monitoring Market witnessing a CAGR of 8.8% during the forecast period 2026-2032.

What is the Therapeutic Drug Monitoring Market size in 2032?

Ans: The Therapeutic Drug Monitoring Market size in 2032 will be US$ 4146 million.

Who are the main players in the Therapeutic Drug Monitoring Market report?

Ans: The main players in the Therapeutic Drug Monitoring Market are Roche, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, bioMerieux, Bühlmann Laboratories, Randox Laboratories, Sekisui Medical, DAT Diagnostic, Chromai

What are the Application segmentation covered in the Therapeutic Drug Monitoring Market report?

Ans: The Applications covered in the Therapeutic Drug Monitoring Market report are Hospital Labs, Independent Clinical Laboratories, Others

What are the Type segmentation covered in the Therapeutic Drug Monitoring Market report?

Ans: The Types covered in the Therapeutic Drug Monitoring Market report are Blood Test, Urine Test, Saliva Test

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Therapeutic Drug Monitoring Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Blood Test

1.2.3 Urine Test

1.2.4 Saliva Test

1.3 Market by Application

1.3.1 Global Therapeutic Drug Monitoring Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital Labs

1.3.3 Independent Clinical Laboratories

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Therapeutic Drug Monitoring Market Perspective (2021–2032)

2.2 Global Therapeutic Drug Monitoring Growth Trends by Region

2.2.1 Global Therapeutic Drug Monitoring Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Therapeutic Drug Monitoring Historic Market Size by Region (2021–2026)

2.2.3 Therapeutic Drug Monitoring Forecasted Market Size by Region (2027–2032)

2.3 Therapeutic Drug Monitoring Market Dynamics

2.3.1 Therapeutic Drug Monitoring Industry Trends

2.3.2 Therapeutic Drug Monitoring Market Drivers

2.3.3 Therapeutic Drug Monitoring Market Challenges

2.3.4 Therapeutic Drug Monitoring Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Therapeutic Drug Monitoring Players by Revenue

3.1.1 Global Top Therapeutic Drug Monitoring Players by Revenue (2021–2026)

3.1.2 Global Therapeutic Drug Monitoring Revenue Market Share by Players (2021–2026)

3.2 Global Top Therapeutic Drug Monitoring Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Therapeutic Drug Monitoring Revenue

3.4 Global Therapeutic Drug Monitoring Market Concentration Ratio

3.4.1 Global Therapeutic Drug Monitoring Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Drug Monitoring Revenue in 2025

3.5 Global Key Players of Therapeutic Drug Monitoring Head Offices and Areas Served

3.6 Global Key Players of Therapeutic Drug Monitoring, Products and Applications

3.7 Global Key Players of Therapeutic Drug Monitoring, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Therapeutic Drug Monitoring Breakdown Data by Type

4.1 Global Therapeutic Drug Monitoring Historic Market Size by Type (2021–2026)

4.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Type (2027–2032)

5 Therapeutic Drug Monitoring Breakdown Data by Application

5.1 Global Therapeutic Drug Monitoring Historic Market Size by Application (2021–2026)

5.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Therapeutic Drug Monitoring Market Size (2021–2032)

6.2 North America Therapeutic Drug Monitoring Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Therapeutic Drug Monitoring Market Size by Country (2021–2026)

6.4 North America Therapeutic Drug Monitoring Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Therapeutic Drug Monitoring Market Size (2021–2032)

7.2 Europe Therapeutic Drug Monitoring Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Therapeutic Drug Monitoring Market Size by Country (2021–2026)

7.4 Europe Therapeutic Drug Monitoring Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Therapeutic Drug Monitoring Market Size (2021–2032)

8.2 Asia-Pacific Therapeutic Drug Monitoring Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2021–2026)

8.4 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Therapeutic Drug Monitoring Market Size (2021–2032)

9.2 Latin America Therapeutic Drug Monitoring Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Therapeutic Drug Monitoring Market Size by Country (2021–2026)

9.4 Latin America Therapeutic Drug Monitoring Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Therapeutic Drug Monitoring Market Size (2021–2032)

10.2 Middle East & Africa Therapeutic Drug Monitoring Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2021–2026)

10.4 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Therapeutic Drug Monitoring Introduction

11.1.4 Roche Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.1.5 Roche Recent Development

11.2 Danaher

11.2.1 Danaher Company Details

11.2.2 Danaher Business Overview

11.2.3 Danaher Therapeutic Drug Monitoring Introduction

11.2.4 Danaher Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.2.5 Danaher Recent Development

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott Therapeutic Drug Monitoring Introduction

11.3.4 Abbott Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.3.5 Abbott Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Introduction

11.4.4 Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Siemens Healthineers

11.5.1 Siemens Healthineers Company Details

11.5.2 Siemens Healthineers Business Overview

11.5.3 Siemens Healthineers Therapeutic Drug Monitoring Introduction

11.5.4 Siemens Healthineers Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.5.5 Siemens Healthineers Recent Development

11.6 Bio-Rad Laboratories

11.6.1 Bio-Rad Laboratories Company Details

11.6.2 Bio-Rad Laboratories Business Overview

11.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Introduction

11.6.4 Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.6.5 Bio-Rad Laboratories Recent Development

11.7 bioMerieux

11.7.1 bioMerieux Company Details

11.7.2 bioMerieux Business Overview

11.7.3 bioMerieux Therapeutic Drug Monitoring Introduction

11.7.4 bioMerieux Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.7.5 bioMerieux Recent Development

11.8 Bühlmann Laboratories

11.8.1 Bühlmann Laboratories Company Details

11.8.2 Bühlmann Laboratories Business Overview

11.8.3 Bühlmann Laboratories Therapeutic Drug Monitoring Introduction

11.8.4 Bühlmann Laboratories Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.8.5 Bühlmann Laboratories Recent Development

11.9 Randox Laboratories

11.9.1 Randox Laboratories Company Details

11.9.2 Randox Laboratories Business Overview

11.9.3 Randox Laboratories Therapeutic Drug Monitoring Introduction

11.9.4 Randox Laboratories Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.9.5 Randox Laboratories Recent Development

11.10 Sekisui Medical

11.10.1 Sekisui Medical Company Details

11.10.2 Sekisui Medical Business Overview

11.10.3 Sekisui Medical Therapeutic Drug Monitoring Introduction

11.10.4 Sekisui Medical Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.10.5 Sekisui Medical Recent Development

11.11 DAT Diagnostic

11.11.1 DAT Diagnostic Company Details

11.11.2 DAT Diagnostic Business Overview

11.11.3 DAT Diagnostic Therapeutic Drug Monitoring Introduction

11.11.4 DAT Diagnostic Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.11.5 DAT Diagnostic Recent Development

11.12 Chromai

11.12.1 Chromai Company Details

11.12.2 Chromai Business Overview

11.12.3 Chromai Therapeutic Drug Monitoring Introduction

11.12.4 Chromai Revenue in Therapeutic Drug Monitoring Business (2021–2026)

11.12.5 Chromai Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Danaher

Abbott

Thermo Fisher Scientific

Siemens Healthineers

Bio Rad Laboratories

Biomerieux

Bühlmann Laboratories

Randox Laboratories

SEKISUI Medical

Chromai

DAT Diagnostic

List of Tables

Table 1. Global Therapeutic Drug Monitoring Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Blood Test

Table 3. Key Players of Urine Test

Table 4. Key Players of Saliva Test

Table 5. Global Therapeutic Drug Monitoring Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Therapeutic Drug Monitoring Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Therapeutic Drug Monitoring Market Size by Region (US$ Million), 2021–2026

Table 8. Global Therapeutic Drug Monitoring Market Share by Region (2021–2026)

Table 9. Global Therapeutic Drug Monitoring Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Therapeutic Drug Monitoring Market Share by Region (2027–2032)

Table 11. Therapeutic Drug Monitoring Market Trends

Table 12. Therapeutic Drug Monitoring Market Drivers

Table 13. Therapeutic Drug Monitoring Market Challenges

Table 14. Therapeutic Drug Monitoring Market Restraints

Table 15. Global Therapeutic Drug Monitoring Revenue by Players (US$ Million), 2021–2026

Table 16. Global Therapeutic Drug Monitoring Market Share by Players (2021–2026)

Table 17. Global Top Therapeutic Drug Monitoring Players by Tier (Tier 1, Tier 2, and Tier 3), based on Therapeutic Drug Monitoring Revenue, 2025

Table 18. Ranking of Global Top Therapeutic Drug Monitoring Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Therapeutic Drug Monitoring Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Therapeutic Drug Monitoring, Headquarters and Area Served

Table 21. Global Key Players of Therapeutic Drug Monitoring, Products and Applications

Table 22. Global Key Players of Therapeutic Drug Monitoring, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Therapeutic Drug Monitoring Market Size by Type (US$ Million), 2021–2026

Table 25. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2021–2026)

Table 26. Global Therapeutic Drug Monitoring Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2027–2032)

Table 28. Global Therapeutic Drug Monitoring Market Size by Application (US$ Million), 2021–2026

Table 29. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2021–2026)

Table 30. Global Therapeutic Drug Monitoring Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2027–2032)

Table 32. North America Therapeutic Drug Monitoring Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Therapeutic Drug Monitoring Market Size by Country (US$ Million), 2021–2026

Table 34. North America Therapeutic Drug Monitoring Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Therapeutic Drug Monitoring Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Therapeutic Drug Monitoring Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Therapeutic Drug Monitoring Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Therapeutic Drug Monitoring Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Therapeutic Drug Monitoring Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Therapeutic Drug Monitoring Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Therapeutic Drug Monitoring Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Therapeutic Drug Monitoring Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (US$ Million), 2027–2032

Table 47. Roche Company Details

Table 48. Roche Business Overview

Table 49. Roche Therapeutic Drug Monitoring Product

Table 50. Roche Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 51. Roche Recent Development

Table 52. Danaher Company Details

Table 53. Danaher Business Overview

Table 54. Danaher Therapeutic Drug Monitoring Product

Table 55. Danaher Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 56. Danaher Recent Development

Table 57. Abbott Company Details

Table 58. Abbott Business Overview

Table 59. Abbott Therapeutic Drug Monitoring Product

Table 60. Abbott Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 61. Abbott Recent Development

Table 62. Thermo Fisher Scientific Company Details

Table 63. Thermo Fisher Scientific Business Overview

Table 64. Thermo Fisher Scientific Therapeutic Drug Monitoring Product

Table 65. Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 66. Thermo Fisher Scientific Recent Development

Table 67. Siemens Healthineers Company Details

Table 68. Siemens Healthineers Business Overview

Table 69. Siemens Healthineers Therapeutic Drug Monitoring Product

Table 70. Siemens Healthineers Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 71. Siemens Healthineers Recent Development

Table 72. Bio-Rad Laboratories Company Details

Table 73. Bio-Rad Laboratories Business Overview

Table 74. Bio-Rad Laboratories Therapeutic Drug Monitoring Product

Table 75. Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 76. Bio-Rad Laboratories Recent Development

Table 77. bioMerieux Company Details

Table 78. bioMerieux Business Overview

Table 79. bioMerieux Therapeutic Drug Monitoring Product

Table 80. bioMerieux Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 81. bioMerieux Recent Development

Table 82. Bühlmann Laboratories Company Details

Table 83. Bühlmann Laboratories Business Overview

Table 84. Bühlmann Laboratories Therapeutic Drug Monitoring Product

Table 85. Bühlmann Laboratories Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 86. Bühlmann Laboratories Recent Development

Table 87. Randox Laboratories Company Details

Table 88. Randox Laboratories Business Overview

Table 89. Randox Laboratories Therapeutic Drug Monitoring Product

Table 90. Randox Laboratories Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 91. Randox Laboratories Recent Development

Table 92. Sekisui Medical Company Details

Table 93. Sekisui Medical Business Overview

Table 94. Sekisui Medical Therapeutic Drug Monitoring Product

Table 95. Sekisui Medical Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 96. Sekisui Medical Recent Development

Table 97. DAT Diagnostic Company Details

Table 98. DAT Diagnostic Business Overview

Table 99. DAT Diagnostic Therapeutic Drug Monitoring Product

Table 100. DAT Diagnostic Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 101. DAT Diagnostic Recent Development

Table 102. Chromai Company Details

Table 103. Chromai Business Overview

Table 104. Chromai Therapeutic Drug Monitoring Product

Table 105. Chromai Revenue in Therapeutic Drug Monitoring Business (US$ Million), 2021–2026

Table 106. Chromai Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Therapeutic Drug Monitoring Picture

Figure 2. Global Therapeutic Drug Monitoring Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Therapeutic Drug Monitoring Market Share by Type: 2025 vs 2032

Figure 4. Blood Test Features

Figure 5. Urine Test Features

Figure 6. Saliva Test Features

Figure 7. Global Therapeutic Drug Monitoring Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Therapeutic Drug Monitoring Market Share by Application: 2025 vs 2032

Figure 9. Hospital Labs Case Studies

Figure 10. Independent Clinical Laboratories Case Studies

Figure 11. Others Case Studies

Figure 12. Therapeutic Drug Monitoring Report Years Considered

Figure 13. Global Therapeutic Drug Monitoring Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Therapeutic Drug Monitoring Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Therapeutic Drug Monitoring Market Share by Region: 2025 vs 2032

Figure 16. Global Therapeutic Drug Monitoring Market Share by Players in 2025

Figure 17. Global Therapeutic Drug Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Therapeutic Drug Monitoring Revenue in 2025

Figure 19. North America Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Therapeutic Drug Monitoring Market Share by Country (2021–2032)

Figure 21. United States Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Therapeutic Drug Monitoring Market Share by Country (2021–2032)

Figure 25. Germany Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Therapeutic Drug Monitoring Market Share by Region (2021–2032)

Figure 33. China Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Therapeutic Drug Monitoring Market Share by Country (2021–2032)

Figure 41. Mexico Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Therapeutic Drug Monitoring Market Share by Country (2021–2032)

Figure 45. Israel Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Therapeutic Drug Monitoring Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Roche Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 49. Danaher Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 50. Abbott Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 52. Siemens Healthineers Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 54. bioMerieux Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 55. Bühlmann Laboratories Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 56. Randox Laboratories Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 57. Sekisui Medical Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 58. DAT Diagnostic Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 59. Chromai Revenue Growth Rate in Therapeutic Drug Monitoring Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global TDM Reagents Market Research Report 2024

Global Therapeutic Drug Monitoring TDM Reagent Kits Market Research Report 2025

Global Therapeutic Drug Monitoring Consumables Market Research Report 2024

Global Theraputic Drug Monitorings Market Research Report 2024

Global Immunosuppressant TDM Assay Kit Market Research Report 2024

Global Targeted Temperature Management System Market Research Report 2024

Global Therapeutic Drug Monitoring Test Market Research Report 2025

Anticoagulant Therapeutic Drug Monitoring Assay Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Trial Management CTM Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Clinical Time of Flight Mass Spectrometry Market Research Report 2025

Transcutaneous Monitoring TCM System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global TDS Monitors Market Research Report 2024

Global Clinical Analyzer Market Research Report 2024

Global Clinical IVD Reagents Market Research Report 2024

Global Medication Therapy Management Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Drug Management System Market Research Report 2025

Clinical Trial Management Software Market

Global Drug Concentration Determination Kit Market Research Report 2024

Global Medication Management System Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions